Fiasp Penfill 100 Iu/ml 3 ML Cartridge

Fiasp Penfill 100 Iu/ml 3 ML Cartridge is mainly used to give insulin for diabetes patient. Fiasp Penfill 100 IU/ml 3 ml Cartridge is a fast-acting insulin aspart solution.

When combined with long-acting insulin, it offers quick blood sugar control when administered before to or soon after meals. Fiasp Penfill 100 Iu/ml 3 ML Cartridge contains Insulin aspart that increases glucose absorption.​

• Gives Insulin

Fiasp Penfill 100 Iu/ml 3 ML Cartridge cause multiple side effects that ranges from common to serious.

• Hypoglycemia
• Injection site reactions
• Weight gain
• Nausea
• Diarrhea
• Upper respiratory infections
• Severe Hypoglycemia
• Hypokalemia
• Allergic reactions
• Pump failure

• Fiasp Penfill 100 Iu/ml 3 ML Cartridge should be administered subcutaneously using a compatible reusable pen like NovoPen by a doctor or an experienced nurse.
• Do not Self Administer.it offers quick blood sugar control when administered before to or soon after meals.​​
  

• Fiasp Penfill 100 Iu/ml 3 ML Cartridge contains Insulin aspart that inhibits hepatic glucose production and increases glucose absorption via GLUT4 transporters via binding to insulin receptors on muscle and fat cells.
• Additionally, it increases protein synthesis and lipogenesis while inhibiting lipolysis and proteolysis.​​
  

• Gammeltoft, S., Hansen, B. F., Dideriksen, L., Lindholm, A., Schäffer, L., Trüb, T., ... & Kurtzhals, P. (1999). Insulin aspart: a novel rapid-acting human insulin analogue. Expert Opinion on Investigational Drugs, 8(9), 1431-1442. https://pubmed.ncbi.nlm.nih.gov/15992160/
• Lindholm, A., & Jacobsen, L. V. (2001). Clinical pharmacokinetics and pharmacodynamics of insulin aspart. Clinical pharmacokinetics, 40(9), 641-659. https://pubmed.ncbi.nlm.nih.gov/11605714/
• Owens, D., & Vora, J. (2006). Insulin aspart: a review. Expert opinion on drug metabolism & toxicology, 2(5), 793-804. https://pubmed.ncbi.nlm.nih.gov/17014395/
• Hermansen, K., Bohl, M., & Schioldan, A. G. (2016). Insulin aspart in the management of diabetes mellitus: 15 years of clinical experience. Drugs, 76(1), 41-74.